医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SmithGroupJJR Opens Office in Shanghai, China

2013年12月05日 PM10:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Russ Sykes, Director of China Operations, SmithGroupJJR (Photo: Business Wire)Russ Sykes, Director of China Operations, SmithGroupJJR (Photo: Business Wire)

View and Share Photo

Close Window


DETROIT

SmithGroupJJR, the oldest architecture and engineering firm in the U.S., has opened an office in Shanghai, China.

Russ Sykes, Director of China Operations, SmithGroupJJR (Photo: Business Wire)

Russ Sykes, Director of China Operations, SmithGroupJJR (Photo: Business Wire)

The 160-year-old SmithGroupJJR, known for its award-winning designs and integrated services, will focus on several of China’s biggest growth markets: research and development, healthcare, continuing care/retirement communities, and higher education.

The new office follows a number of significant projects SmithGroupJJR has designed in China in recent years, serving Chinese clients and U.S.-based companies expanding their operations to China. In Changchun, the firm designed the new 468,000-square-meter (5.0 million square feet) automotive research and development center for First Automotive Works, China’s leading manufacturer of passenger cars and commercial trucks and buses. Now under construction, the project will be completed in 2015.

Continuing care/retirement community design is another area of expertise successfully brought to China by SmithGroupJJR. Starting construction this fall in Shanghai is the 21-story ZhongShan Park, a continuing care retirement community SmithGroupJJR designed for the Vcanland Senior Living Group.

Leading SmithGroupJJR’s China operations is Russ Sykes, a 28-year veteran of the firm. Sykes is dividing his time between Shanghai and the SmithGroupJJR office in Detroit, Mich., where he’s spent most of his career.

“Many of our China-based clients, like First Automotive Works, traveled to the U.S. and sought us out for our specialized design expertise,” Sykes said. “Now, with the new office, our clients in Shanghai have direct access to our services. Simultaneously, they benefit from the alliances we’ve established and our understanding of how to work in China,” Sykes added .

SmithGroupJJR President & CEO Carl Roehling believes the growing healthcare market in China will help the firm succeed.

“Clients are requesting the level of design expertise we possess,” Roehling said. “For the growing healthcare market in China, there is a need for firms that excel in healthcare design and the advanced technology used in hospitals. We have that expertise,” he added.

SmithGroupJJR is ranked as the 10th largest healthcare design firm in the world by the 2013 edition of World Architecture 100, published by Building Design magazine. In Shanghai, SmithGroupJJR designed Shuguang Hospital for Shanghai Traditional Chinese Medical University. The firm’s U.S. clients include the National Institutes of Health, St. Jude Children’s Research Hospital, Stanford University Medical Center, and Kaiser Permanente.

SmithGroupJJR’s China office is located in the Puxi area of Shanghai. The address is Suite A409, Tomorrow Square, 399 W. Nanjing Road, Shanghai, 200003. The phone number is 86 21 2308 1188.

SmithGroupJJR is the oldest continually operating architecture and engineering firm in the U.S., founded in 1853. The firm consistently ranks top 10 in the U.S. in the primary client markets it serves: healthcare, science & technology, higher education and workplace. A leader in sustainable design, SmithGroupJJR has completed 91 LEED certified projects to date. The firm’s U.S. offices are located in Ann Arbor, MI; Chicago, IL; Dallas, TX; Detroit, MI; Madison, WI; Los Angeles, CA; Phoenix, AZ; San Francisco, CA; and Washington, DC.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131205005016/en/

CONTACT

SmithGroupJJR
Sandra Knight, APR
313.442.8470
sandra.knight@smithgroupjjr.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表